%PDF- %PDF-
| Direktori : /home/vacivi36/mail/.ramiro_ortigoso@vacivitta_com_br/.GRIPE 2024.EPE/ |
| Current File : /home/vacivi36/mail/.ramiro_ortigoso@vacivitta_com_br/.GRIPE 2024.EPE/dovecot.index.cache |
LU�h~�si. $ p ��������O �si ~�si �si �si ���������������� ���������������� � flags date.sent date.received date.save size.virtual size.physical imap.body imap.bodystructure imap.envelope pop3.uidl pop3.order guid mime.parts binary.parts body.snippet �j�f �i�f :W�f 1 �f Ѭ�f )��f (��f pd�f ��f ���f �m�f �q�f ���f ���f r��f X��f �q�f p�f P�f ��f d�f U g oJ g ��g N6g U
g �Sg 5�g $� g I2g ��4g �S?g ��@g � Sg �LSg �jQh����h �si ~�si ��wi ��wi ��wi ���������������� �������������������� � flags date.sent date.received date.save size.virtual size.physical imap.body imap.bodystructure imap.envelope pop3.uidl pop3.order guid mime.parts binary.parts body.snippet hdr.MESSAGE-ID t d Message-ID: <CP4P284MB284498EF5B2B9000B59A2DBCB7472@CP4P284MB2844.BRAP284.PROD.OUTLOOK.COM>
t d Message-ID: <CP4P284MB28444A16C9D7B47B6EE72D31B74A2@CP4P284MB2844.BRAP284.PROD.OUTLOOK.COM>
0 t d Message-ID: <CP4P284MB256462589F7636946A825F89DD4B2@CP4P284MB2564.BRAP284.PROD.OUTLOOK.COM>
@ t d Message-ID: <CP4P284MB25646798CFC297219E7E2557DD582@CP4P284MB2564.BRAP284.PROD.OUTLOOK.COM>
P t d Message-ID: <CP4P284MB256409F63718BC34D78666ECDD5A2@CP4P284MB2564.BRAP284.PROD.OUTLOOK.COM>
` t d Message-ID: <ROAP284MB25719948892615C2142F31C8DD222@ROAP284MB2571.BRAP284.PROD.OUTLOOK.COM>
p t d Message-ID: <CP4P284MB25647FFDBDA54C93FC708BA9DD232@CP4P284MB2564.BRAP284.PROD.OUTLOOK.COM>
� t d Message-ID: <CP4P284MB2844962ED9455D188CAC9286B7312@CP4P284MB2844.BRAP284.PROD.OUTLOOK.COM>
� t d Message-ID: <CP4P284MB2844776CDE9E8755DB5D04E1B7312@CP4P284MB2844.BRAP284.PROD.OUTLOOK.COM>
� t d Message-ID: <CP5P284MB2449865AA06F3770D647C844DD73A@CP5P284MB2449.BRAP284.PROD.OUTLOOK.COM>
~ ��wi ��wi ��wi ��wi ��xi��wi ���������������� ������������������������ � flags date.sent date.received date.save size.virtual size.physical imap.body imap.bodystructure imap.envelope pop3.uidl pop3.order guid mime.parts binary.parts body.snippet hdr.MESSAGE-ID hdr.SUBJECT 8 ( Subject: Campanha Novembro Azul
� @ - Subject: RES: Campanha Novembro Azul
H 5 Subject: Lista Autorizados Vacina atualizada
t P ? Subject: =?iso-8859-1?Q?Lista_vacinados_na_cl=EDnica?=
� ` O Subject: =?iso-8859-1?Q?Autoriza=E7=E3o__Vacina=E7=E3o_-_Dependende_?=
\ P ? Subject: =?iso-8859-1?B?QXV0b3JpemHn428gVmFjaW5h5+Nv?=
� P ? Subject: =?iso-8859-1?B?QXV0b3JpemHn428gVmFjaW5h5+Nv?=
D � w Subject: =?iso-8859-1?Q?CT-EPE-052-2024_-_Faturamento_aplica=E7=F5es_de_2024_na_?=
=?iso-8859-1?Q?cl=EDnica?=
� � | Subject: =?iso-8859-1?Q?RES:_CT-EPE-052-2024_-_Faturamento_aplica=E7=F5es_de_2024_?=
=?iso-8859-1?Q?na_cl=EDnica?=
, � � Subject: =?Windows-1252?Q?Agendamento_de_Novas_Datas_de_Aplica=E7=E3o_=96_Vacina_P?=
=?Windows-1252?Q?neumo_15_=28Contrato_CT-EPE-052/2024=29?=
p � G Message-ID: <002701db1021$99408830$cbc19890$@vacivitta.com.br>
� Subject: =?utf-8?Q?RES:_Proposta_Comercial_-_Vacina?=
=?utf-8?Q?_contra_doen=C3=A7a_pneumoc=C3=B3cica_=28PNE?=
=?utf-8?Q?UMO_15=29?=
� @ � Message-ID: <!&!AAAAAAAAAAAuAAAAAAAAAGMx3swmx5ZIgOOqXYqtGHABAMO2jhD3dRHOtM0AqgC7tuYAAAAAAA4AABAAAACKWtDvexwSRJHEm7WGdGLFAQAAAAA=@vacivitta.com.br>
� Subject: =?utf-8?Q?RES:_Faturamento_EPE_-_Vacina_co?=
=?utf-8?Q?ntra_doen=C3=A7a_pneumoc=C3=B3cica_=28PNEUMO?=
=?utf-8?Q?_15=29?=
� � d Message-ID: <CP4P284MB2844DC648F46D3E6D1D5FD1DB7722@CP4P284MB2844.BRAP284.PROD.OUTLOOK.COM>
u Subject: =?iso-8859-1?Q?Vacina=E7=E3o_familiar_colaboradora_Rosilene_Santos_de_Oli?=
=?iso-8859-1?Q?veira?=
� � d Message-ID: <CP4P284MB2844410C893D7AA1CC4B1B2AB7722@CP4P284MB2844.BRAP284.PROD.OUTLOOK.COM>
z Subject: =?iso-8859-1?Q?RES:_Vacina=E7=E3o_familiar_colaboradora_Rosilene_Santos_d?=
=?iso-8859-1?Q?e_Oliveira?=
� � G Message-ID: <009e01db165c$791ede30$6b5c9a90$@vacivitta.com.br>
z Subject: =?iso-8859-1?Q?RES:_Vacina=E7=E3o_familiar_colaboradora_Rosilene_Santos_d?=
=?iso-8859-1?Q?e_Oliveira?=
� � G Message-ID: <01fe01db166d$200d4af0$6027e0d0$@vacivitta.com.br>
� Subject: =?utf-8?Q?RES:_Faturamento_EPE_-_Vacina_co?=
=?utf-8?Q?ntra_doen=C3=A7a_pneumoc=C3=B3cica_=28PNEUMO?=
=?utf-8?Q?_15=29?=
� � d Message-ID: <CP4P284MB256432B956280C95061AFC01DD722@CP4P284MB2564.BRAP284.PROD.OUTLOOK.COM>
M Subject: =?iso-8859-1?Q?Lista_Vacina=E7=E3o_Pneumo15=5FAutorizados?=
� � G Message-ID: <023501db18c0$492c0250$db8406f0$@vacivitta.com.br>
R Subject: =?iso-8859-1?Q?ENC:_Lista_Vacina=E7=E3o_Pneumo15=5FAutorizados?=
� � d Message-ID: <CP5P284MB244987C056279C7B71950BFFDD7D2@CP5P284MB2449.BRAP284.PROD.OUTLOOK.COM>
S Subject: =?Windows-1252?Q?RE:_Lista_Vacina=E7=E3o_Pneumo15=5FAutorizados?=
� d Message-ID: <CP4P284MB2564940BCDA7200E497FCA39DD442@CP4P284MB2564.BRAP284.PROD.OUTLOOK.COM>
? Subject: =?iso-8859-1?Q?Lista_vacinados_na_cl=EDnica?=
� d Message-ID: <CP5P284MB2449D6EC977DDAA30F83CAE0DD972@CP5P284MB2449.BRAP284.PROD.OUTLOOK.COM>
� Subject: =?UTF-8?Q?RE:_Proposta_Comercial_-_Vacina_?=
=?UTF-8?Q?contra_doen=C3=A7a_pneumoc=C3=B3cica_=28PNEU?=
=?UTF-8?Q?MO_15=29?=
� d Message-ID: <CP5P284MB2449422292C7DC8D14F84945DD9A2@CP5P284MB2449.BRAP284.PROD.OUTLOOK.COM>
� Subject: =?UTF-8?Q?RE:_Proposta_Comercial_-_Vacina_?=
=?UTF-8?Q?contra_doen=C3=A7a_pneumoc=C3=B3cica_=28PNEU?=
=?UTF-8?Q?MO_15=29?=
� d Message-ID: <CP5P284MB2449C6794D01ACED480751CFDD9A2@CP5P284MB2449.BRAP284.PROD.OUTLOOK.COM>
� Subject: =?UTF-8?Q?RE:_Proposta_Comercial_-_Vacina_?=
=?UTF-8?Q?contra_doen=C3=A7a_pneumoc=C3=B3cica_=28PNEU?=
=?UTF-8?Q?MO_15=29?=
d Message-ID: <CP4P284MB256439FE816322ED2DB44048DD9B2@CP4P284MB2564.BRAP284.PROD.OUTLOOK.COM>
� Subject: =?UTF-8?Q?RE:_Proposta_Comercial_-_Vacina_?=
=?UTF-8?Q?contra_doen=C3=A7a_pneumoc=C3=B3cica_=28PNEU?=
=?UTF-8?Q?MO_15=29?=
� G Message-ID: <004c01db08f8$3ce82500$b6b86f00$@vacivitta.com.br>
� Subject: =?utf-8?Q?RES:_Proposta_Comercial_-_Vacina?=
=?utf-8?Q?_contra_doen=C3=A7a_pneumoc=C3=B3cica_=28PNE?=
=?utf-8?Q?UMO_15=29?=
d Message-ID: <CP5P284MB2449BC19D4E15A661A09C30DDD6F2@CP5P284MB2449.BRAP284.PROD.OUTLOOK.COM>
� Subject: =?UTF-8?Q?RE:_Proposta_Comercial_-_Vacina_?=
=?UTF-8?Q?contra_doen=C3=A7a_pneumoc=C3=B3cica_=28PNEU?=
=?UTF-8?Q?MO_15=29?=
0 � G Message-ID: <003001db0e7c$67aa28e0$36fe7aa0$@vacivitta.com.br>
� Subject: =?UTF-8?Q?RES:_Proposta_Comercial_-_Vacina?=
=?UTF-8?Q?_contra_doen=C3=A7a_pneumoc=C3=B3cica_=28PNE?=
=?UTF-8?Q?UMO_15=29?=
@ � G Message-ID: <007701db0e8f$cce16f80$66a44e80$@vacivitta.com.br>
� Subject: =?UTF-8?Q?RES:_Proposta_Comercial_-_Vacina?=
=?UTF-8?Q?_contra_doen=C3=A7a_pneumoc=C3=B3cica_=28PNE?=
=?UTF-8?Q?UMO_15=29?=
P d Message-ID: <CP5P284MB2449C6CA05DF78577F1D3422DD682@CP5P284MB2449.BRAP284.PROD.OUTLOOK.COM>
� Subject: =?UTF-8?Q?RE:_Proposta_Comercial_-_Vacina_?=
=?UTF-8?Q?contra_doen=C3=A7a_pneumoc=C3=B3cica_=28PNEU?=
=?UTF-8?Q?MO_15=29?=
` d Message-ID: <CP5P284MB24497F12ED975796EDA6F845DD6A2@CP5P284MB2449.BRAP284.PROD.OUTLOOK.COM>
� Subject: =?utf-8?Q?RE:_Proposta_Comercial_-_Vacina_?=
=?utf-8?Q?contra_doen=C3=A7a_pneumoc=C3=B3cica_=28PNEU?=
=?utf-8?Q?MO_15=29?=
p d Message-ID: <CP5P284MB2449545900AB47DD56A1FFCBDDB12@CP5P284MB2449.BRAP284.PROD.OUTLOOK.COM>
� Subject: =?utf-8?Q?RE:_Proposta_Comercial_-_Vacina_?=
=?utf-8?Q?contra_doen=C3=A7a_pneumoc=C3=B3cica_=28PNEU?=
=?utf-8?Q?MO_15=29?=
� D � Message-ID: <!&!AAAAAAAAAAAuAAAAAAAAAGMx3swmx5ZIgOOqXYqtGHABAMO2jhD3dRHOtM0AqgC7tuYAAAAAAA4AABAAAAALaZyfPKMUTYoN7df6MaZMAQAAAAA=@vacivitta.com.br>
� Subject: =?utf-8?Q?RES:_Proposta_Comercial_-_Vacina?=
=?utf-8?Q?_contra_doen=C3=A7a_pneumoc=C3=B3cica_=28PNE?=
=?utf-8?Q?UMO_15=29?=
� � d Message-ID: <CP8P284MB28731588DC037FFE5E483AC1CC8C2@CP8P284MB2873.BRAP284.PROD.OUTLOOK.COM>
L Subject: DL.EPE.041/2024 - CT-EPE-052/2024 - Assinatura do Contrato
� � d Message-ID: <CP8P284MB2873DB79FC9EEBF6094C38F3CC8E2@CP8P284MB2873.BRAP284.PROD.OUTLOOK.COM>
Q Subject: RES: DL.EPE.041/2024 - CT-EPE-052/2024 - Assinatura do Contrato
� � U Message-ID: <66ccaca4834d_1d6f24132474@tavola-sidekiq-65f97bbd86-n62xh.mail>
M Subject: Comprovante de assinatura do documento: CT-EPE-052-2024.pdf
� � d Message-ID: <CP8P284MB2873A4F1E032296F41EB1F80CC8B2@CP8P284MB2873.BRAP284.PROD.OUTLOOK.COM>
F Subject: DL.EPE.041/2024 - CT-EPE-052/2024 -Contrato Assinado